Autoantibodies in viral hepatitis-related hepatocellular carcinoma

Intervirology

Volumn 35, Issue 1-4, 1993, Pages 73-85

  Imai, H ^a   Kiyosawa, K ^b   Chan, E K L ^a   Tan, E M ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoantibodies; Autoimmunity; Hepatitis, viral; Hepatocellular carcinoma; Nuclear antigens; Nucleolar antigens

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CELL NUCLEUS ANTIGEN; COMPLEMENTARY DNA; DNA DIRECTED RNA POLYMERASE; NUCLEOPHOSMIN; RIBONUCLEOPROTEIN;

ADULT; AGED; CHROMOSOME NOR; CHRONIC LIVER DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; VIRUS CELL TRANSFORMATION; VIRUS HEPATITIS;

AUTOANTIBODIES; AUTOANTIGENS; CARCINOMA, HEPATOCELLULAR; HEPATITIS; HUMAN; NUCLEAR PROTEINS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027257749     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000150297     Document Type: Article

References (38)

1. Whitehousc JMA. Holborow EJ: Smooth muscle antibody in malignant disease. BMJ 1971:27:511-513
2. Burnham TK: Anlinuclear antibodies in patients with malignancies. Lancet 1972:2:436-437.
3. Gray ES. McLay ALC. Thompson WD. Donald D. Home CHW: Non-organ specific autoantibodies in malignant diseases. Scott Med J 1975: 20:203-208.
4. Steiner M. Klein E. Klein G: Antinu-clear reactivity of sera in patients with leukemia and other neoplastic diseases. Clin Immunol Immunopa-thol 1975;4:374-381.
5. Thomas PJ. Kaur JS. Aitcheson CT. Robinson WA. Tan EM: Antinucle-ar. antinuclcolar. and anticytoplas-mic antibodies in patients with malignant melanoma. Cancer Res 1983: 43:1372-1380.
6. Hodson ME. Turner-Warwick M: Autoantibodies in patients with bronchial carcinoma. Thorax 1975: 30:367-370.
7. Wasserman J. Glas U. Blomgren H: Autoantibodies in patients with carcinoma of the breast: correlation with prognosis. Clin Exp Immunol 1975:19:417-422.
8. Schattner A. Shani A. Talpaz M. Bentwich Z: Rheumatoid factors in the sera of patients with gastrointestinal carcinoma. Cancer 1983:52: 2156-2161.
9. Lamelin JP. de-The G. Revillard JP. Gabbiani G: Autoantibodies (cold lymphocytotoxins, antiactin antibodies and antinuclear factors) in nasopharyngeal carcinoma patients. IARCSci Publ 1978:20:523-536.
10. Ablin RJ: Malignancy associated with antinuclear antibodies. Lancet 1972:2:1253-1254.
11. Bonfa E, Bystryn J-C, Elkon KB: Detection of immunoglobulin G antibodies in melanoma sera reactive with intracellular proteins. J Invest Dermatol 1988:90:207-212.
12. Kiyosawa K. lmai H. Sodeyama T. Furuta K. Gibo Y. Kumagai T. Ka-meko M. Kanai M. Furuta S: Scrum auto-antibodies in patients with hepatocellular carcinoma: the clinical significance of antinuclear antibody. J Gastroenterol Hepatol 1986:1: 371-378.
13. Chen Y-M. Hu C-P. Chen P-H. Chu M-HH. Tsai Y-T. Lee S-D. Chang C: Nuclear antigens reacted with sera and ascites of hepatocellular carcinoma patients. Hcpatology 1988:8: 547-552.
14. Kiyosawa K, Daemer RJ, He L-F, Bonino F. Prozesky OW, Pureell RH: The spectrum of complement-fixing antinuclear antibodies in patients with hepatocellular carcinoma. Hepatology 1985:5:548-555.
15. Dropcho EJ. Stanton C. Oh SJ: Neuronal anlinuclear antibodies in a patient with Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma. Neurology 1989:39: 249-251.
16. Polans AS. Buezylko J. Crabb J. Palczewski K: A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy. J Cell Biol 1991;112:981-989.
17. Sakai K. Mitchell DJ. Tsukamoto T. Steinman L: Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti-neuronal cell antibody from a patient with paraneoplastic cerebellar degeneration. Ann Neurol 1990.28: 692-698.
18. Szabo A. Dalmau J. Manley G. Ro-senfeld M. Wong E. Henson J. Posner J-B. Furneaux HM: HuD. a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to elav and sex-lethal. Cell 1991:67:325-333.
19. Tan EM: Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989:44:93-151.
20. Imai H. Ochs RL. Kiyosawa K. Furuta S. Nakamura RM. Tan EM: Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies. Am J Pathol 1992:140:859-870.
21. lmai H. Nakano Y. Kiyosawa K. Tan EM: Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma. Cancer 1993:71: 26-35.
22. lmai H. Chan EKL. Tan EM: Molecular cloning of a 64 kDa nuclear protein targeted by autoantibody in a patient with hepatocellular carcinoma. Arthritis Rheum 1992:35 (suppl):l70.
23. Ochs R. Lischwe M. O'Leary P. Busch H: Localization of nucleolar phosphoproteins B23 and C23 during mitosis. Exp Cell Res 1983:146: 139-149.
24. Feuerstein N. Chan PK. Mond JJ: Identification of numatrin. the nuclear matrix protein associated with induction of mitogencsis. as the nucleolar protein B23: Implication for the role of the nucleolus in early transduction of mitogenic signals. J BiolChem 1988:263:10608-10612.
25. Reimer G. Pollard KM. Penning CA. Ochs RL. Lischwe MA. Busch H. Tan EM: Monoclonal antibody from a (New Zealand black X New Zealand white) Fl mouse and some human scleroderma sera target, an Mr 34.000 nucleolar protein of the U3 RNP particle. Arthritis Rheum 1987:30:793-800.
26. Kass S. Tyc K. Steitz JA. Sollner-Webb B: The U3 small nucleolar ribonucleoprotein functions in the first step of pre-ribosomal RNA processing. Cell 1990:60:897-908.
27. Jantzen H-M. Admon A. Bell SP. Tjian R: Nucleolar transcription factor hUBF contains a DNA-bind-ing motif with homology to HMG proteins. Nature 1990:344:830-836.
28. Chan EKL. lmai H. Hamel JC. Tan EM: Human autoantibody to RNA polymerase I transcription factor hUBF: Molecular identity of nucleolar organizer region autoantigen NOR-90 and ribosomal RNA transcription upstream binding factor. J Exp Med 1991:174:1239-1244.
29. Howell WM: Selective staining of nucleolus organizer regions (NORs): in Busch H. Rothblum LI (eds): The Cell Nucleus. Part B: rDNA. Vol 50 New York. Academic Press. 1982. pp 89-142.
30. Goodpasture C. Bloom SE: Visualization of nucleolar organizer regions in mammalian chromosomes using silver staining. Chromosoma 1975: 53:37-50.
31. Burlingame RW., Rubin RL: Subnu-cleosome structures as substrates in enzyme-linked immunsorbcnt assays. J Immunol Methods 1990:134: 187-199.
32. Huff JP. Roos G. Peebles CL. Houghton RA. Sullivan KF. Tan EM: Insights into native epitopes of proliferating cell nuclear antigen using recombinant DNA protein products. J Exp Med 1990:172:419-429.
33. Tan EM. Chan EKL: Molecular biology of autoantigens and new insights into autoimmunity. Clin Investigator 1993. in press.
34. Popper H. Shafrilz DA. Hoofnagle JH: Relation of the hepatitis B virus carrier state to hepatocellar carcinoma. Hepatology 1987:7:764-772.
35. Chisari FV. KJopchin K. Moriyama T. Pasquinelli C. Dunsford HA. Sell S. Pinkert CA. Brinster RL. Pal-miter RD: Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 1989:59:1145-1156.
36. Popper H. Roth L. Purcell RH. Ten-nanl BC. Gerin JL: Hepatocarcino-genicily of Ihc woodchuck hepatitis virus. Proc Natl Acad Sci USA 1987;84:866-870.
37. Dusheiko GM. Hobbs KEF. Dick R. Burroughs AK: Treatment of small hepatocellular carcinoma. Lancet 1992:340:285-288.
38. Okuda K: Early recognition of liver cell tumors; in Bannasch P. Keppler D. Weber G (eds): Liver Cell Carcinoma. Boston. Kluwer. 1989. pp 439-453.